+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 55Years
All Genders
Healthy Volunteers
ID07673913

Evaluating Intermittent Theta Burst Stimulation Effects on Biomarkers and Symptoms in Treatment-Resistant Depression

Led by Gulhane Training and Research Hospital · Updated on 2026-09-14

100

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Treatment-resistant depression TRD affects many patients with major depressive disorder who do not respond well to standard antidepressant medications. This study evaluates the effects of intermittent theta burst stimulation iTBS, a non-invasive brain stimulation targeting the left dorsolateral prefrontal cortex, on clinical symptoms, executive functions, and biological markers in patients with TRD. The goal is to better understand the biological mechanisms linked to treatment response and identify potential biomarkers for improved personalized care. Participants include 50 patients with TRD and 50 healthy controls. Patients will receive active iTBS treatment using a MagVenture X100 device, delivering 1800 pulses per session at 90% of resting motor threshold, five times per week for four weeks total 20 sessions. Healthy controls will only undergo baseline assessments without intervention. Patients will continue their usual medication during the study. Participants will undergo clinical evaluations using depression and insomnia rating scales, and cognitive tests assessing executive function before and after treatment. Blood samples will be collected to measure inflammatory and neuroprotective biomarkers and gene expression. The primary outcome is change in depression severity after four weeks. Secondary outcomes include changes in other clinical scores, cognitive performance, biomarkers, and gene expression profiles. The study aims to support biomarker-guided personalized neuromodulation strategies for TRD.

CONDITIONS

Brief Title

Relationship of Peripheral Inflammatory and Neuroprotective Biomarkers With Response to Intermittent Theta Burst Stimulation in Treatment-Resistant Depression

Research Team

B

BEYAZIT GARİP, Principal Investigator

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here